News

Researchers have created an artificial intelligence model called CODE-AE that could significantly improve the accuracy, time and cost of the drug development process. Researchers hope this will accelerate drug discovery and precision medicine.

According to research, a combination of a novel small inhibitory molecule and an FDA-approved chemotherapy drug can suppress the growth of triple-negative breast cancer cells synergistically.

Cancer-induced muscle wasting is a common complication in the late stages of cancer. New research has identified a key enzyme that drives the condition, opening doors to developing treatments.

The National Institutes of Health's National Institute of Allergy and Infectious Diseases has awarded two nonprofit research organizations with a $3.5 million, five-year Innovation for Tuberculosis Vaccine Discovery grant.

Researchers have investigated how breast cancer cells become resistant to endocrine therapy, revealing a mechanism that both explains the process and offers possibilities to overcome it.

Researchers have discovered that activating a specific protein in chondrocytes, a critical cell type that maintains healthy cartilage in joints, could restore multiple factors needed for smooth joints, helping to control inflammation.

Researchers have discovered that the rheumatoid arthritis drug auranofin can potentially be repurposed to improve diabetes-associated symptoms, following a study in mice.

According to research, a new therapy currently undergoing clinical trials promotes a potent immune response by binding to fibroblasts, enabling it to overcome resistance to anti-HER2 therapy in tumors.

Researchers used novel drug discovery technologies to uncover a metabolite that converts white fat cells (“bad” fat) to brown fat (“good” fat) cells. This discovery offers a potential way of addressing metabolic conditions like obesity, type 2 diabetes and cardiovascular disease.

Researchers have developed a computer-program-generated library of antibiotics and have used this to identify an effective antibiotic for targeted use in a bone cement matrix.